Selected research
Industry Growth & Trends
Global Mood Stabilizers Industry Growth and Trends Forecast to 2032
Market perspective
The global Mood Stabilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mood Stabilizers include Pfizer, GlaxoSmithKline, Otsuka Pharmaceutical and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mood Stabilizers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mood Stabilizers market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mood Stabilizers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mood Stabilizers.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Mood Stabilizers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mood Stabilizers Market by Company
Pfizer
GlaxoSmithKline
Otsuka Pharmaceutical
Bristol-Myers Squibb
Mood Stabilizers Segment by Type
Asenapine
Valproate
Carbamazepine
Lamotrigine
Mood Stabilizers Segment by Application
Hospital Pharmacies
Drug Stores
Others
Mood Stabilizers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mood Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mood Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mood Stabilizers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mood Stabilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Mood Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Asenapine
- Valproate
- Carbamazepine
- Lamotrigine
Applications
- Hospital Pharmacies
- Drug Stores
- Others
Companies covered
- Pfizer
- GlaxoSmithKline
- Otsuka Pharmaceutical
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Mood Stabilizers Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Mood Stabilizers Sales Estimates and Forecasts (2021-2032)
- 1.3 Mood Stabilizers Market by Type
- 1.3.1 Asenapine
- 1.3.2 Valproate
- 1.3.3 Carbamazepine
- 1.3.4 Lamotrigine
- 1.4 Global Mood Stabilizers Market Size by Type
- 1.4.1 Global Mood Stabilizers Market Size Overview by Type (2021-2032)
- 1.4.2 Global Mood Stabilizers Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Mood Stabilizers Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Mood Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Mood Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Mood Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Mood Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Mood Stabilizers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Mood Stabilizers Industry Trends
- 2.2 Mood Stabilizers Industry Drivers
- 2.3 Mood Stabilizers Industry Opportunities and Challenges
- 2.4 Mood Stabilizers Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Mood Stabilizers Revenue (2021-2026)
- 3.2 Global Top Players by Mood Stabilizers Sales (2021-2026)
- 3.3 Global Top Players by Mood Stabilizers Price (2021-2026)
- 3.4 Global Mood Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mood Stabilizers Major Company Production Sites & Headquarters
- 3.6 Global Mood Stabilizers Company, Product Type & Application
- 3.7 Global Mood Stabilizers Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mood Stabilizers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mood Stabilizers Players Market Share by Revenue in 2025
- 3.8.3 2025 Mood Stabilizers Tier 1, Tier 2, and Tier 3
4 Mood Stabilizers Regional Status and Outlook
- 4.1 Global Mood Stabilizers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Mood Stabilizers Historic Market Size by Region
- 4.2.1 Global Mood Stabilizers Sales in Volume by Region (2021-2026)
- 4.2.2 Global Mood Stabilizers Sales in Value by Region (2021-2026)
- 4.2.3 Global Mood Stabilizers Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Mood Stabilizers Forecasted Market Size by Region
- 4.3.1 Global Mood Stabilizers Sales in Volume by Region (2027-2032)
- 4.3.2 Global Mood Stabilizers Sales in Value by Region (2027-2032)
- 4.3.3 Global Mood Stabilizers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mood Stabilizers by Application
- 5.1 Mood Stabilizers Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Drug Stores
- 5.1.3 Others
- 5.2 Global Mood Stabilizers Market Size by Application
- 5.2.1 Global Mood Stabilizers Market Size Overview by Application (2021-2032)
- 5.2.2 Global Mood Stabilizers Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Mood Stabilizers Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Mood Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Mood Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Mood Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Mood Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Mood Stabilizers Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Pfizer
- 6.1.1 Pfizer Company Information
- 6.1.2 Pfizer Business Overview
- 6.1.3 Pfizer Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Pfizer Mood Stabilizers Product Portfolio
- 6.1.5 Pfizer Recent Developments
- 6.2 GlaxoSmithKline
- 6.2.1 GlaxoSmithKline Company Information
- 6.2.2 GlaxoSmithKline Business Overview
- 6.2.3 GlaxoSmithKline Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 GlaxoSmithKline Mood Stabilizers Product Portfolio
- 6.2.5 GlaxoSmithKline Recent Developments
- 6.3 Otsuka Pharmaceutical
- 6.3.1 Otsuka Pharmaceutical Company Information
- 6.3.2 Otsuka Pharmaceutical Business Overview
- 6.3.3 Otsuka Pharmaceutical Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Otsuka Pharmaceutical Mood Stabilizers Product Portfolio
- 6.3.5 Otsuka Pharmaceutical Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Bristol-Myers Squibb Mood Stabilizers Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
- 7.1 North America Mood Stabilizers Sales by Country
- 7.1.1 North America Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Mood Stabilizers Sales by Country (2021-2026)
- 7.1.3 North America Mood Stabilizers Sales Forecast by Country (2027-2032)
- 7.2 North America Mood Stabilizers Market Size by Country
- 7.2.1 North America Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Mood Stabilizers Market Size by Country (2021-2026)
- 7.2.3 North America Mood Stabilizers Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Mood Stabilizers Sales by Country
- 8.1.1 Europe Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Mood Stabilizers Sales by Country (2021-2026)
- 8.1.3 Europe Mood Stabilizers Sales Forecast by Country (2027-2032)
- 8.2 Europe Mood Stabilizers Market Size by Country
- 8.2.1 Europe Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Mood Stabilizers Market Size by Country (2021-2026)
- 8.2.3 Europe Mood Stabilizers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Mood Stabilizers Sales by Country
- 9.1.1 Asia-Pacific Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Mood Stabilizers Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Mood Stabilizers Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Mood Stabilizers Market Size by Country
- 9.2.1 Asia-Pacific Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Mood Stabilizers Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Mood Stabilizers Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Mood Stabilizers Sales by Country
- 10.1.1 South America Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Mood Stabilizers Sales by Country (2021-2026)
- 10.1.3 South America Mood Stabilizers Sales Forecast by Country (2027-2032)
- 10.2 South America Mood Stabilizers Market Size by Country
- 10.2.1 South America Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Mood Stabilizers Market Size by Country (2021-2026)
- 10.2.3 South America Mood Stabilizers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Mood Stabilizers Sales by Country
- 11.1.1 Middle East and Africa Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Mood Stabilizers Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Mood Stabilizers Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Mood Stabilizers Market Size by Country
- 11.2.1 Middle East and Africa Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Mood Stabilizers Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Mood Stabilizers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Mood Stabilizers Value Chain Analysis
- 12.1.1 Mood Stabilizers Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Mood Stabilizers Production Mode & Process
- 12.2 Mood Stabilizers Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Mood Stabilizers Distributors
- 12.2.3 Mood Stabilizers Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst